期刊文献+

肝癌靶向液态氟碳脂质微球造影剂的体外寻靶实验研究 被引量:2

Targeting study in vitro of human hepatocellular carcinoma-targeted perfluorocarbon lipid particles
原文传递
导出
摘要 目的制备液态氟碳脂质微球造影剂并研究其体外基本特性,再引入抗人肝癌细胞单克隆抗体,采用生物素亲和素法,进行体外靶向结合的研究。方法采用旋转蒸发法和高压均质法制备一种纳米液态氟碳脂质微球造影剂,观察其外观、形态、大小及分布情况,计算其浓度,并测定其粒径、电位;制备生物素的抗人肝癌细胞单克隆抗体HAb18,用HABA/Avidin试剂盒检测抗体的生物素化程度;制备NBD标记的生物素化的微球,采用生物素亲和素法研究其体外靶向作用。结果所制备的液态氟碳脂质微球造影剂外观呈乳白色的混悬液,镜下观察,微球形态圆整,大小均一,性质稳定,平均粒径171.9nm;采用生物素亲和素法制备的NBD标记的生物素化的微球可靶向结合到靶细胞上。结论成功制备出稳定的纳米液态氟碳脂质微球造影剂,并引入抗人肝癌细胞单克隆抗体,通过生物素亲和素系统可将其特异结合到靶细胞上。 Objective To develop perfluorocarbon lipid particles and investigate their basic properties,and target them to human hepatocellular carcinoma cells in vitro by hepatoma monocolonal antibody HAb18 with avidin-biotin interaction. Methods Rotary evaporation and high pressure homogen were used to prepare perfluorocarbon lipid particles, and the appearance and distribution of them were investigated by microscope and electron microscope, the concentration and the size and electric potential were detected. The biotinylated monoclonal antibody HAb18 was prepared, then the biotinylated degree of the antibody was determined. The biotinylated perfluorocarbon lipid particles labelled with NBD were prepared and targeted to human hepatocellular carcinoma cells in vitro with avidin-biotin interaction. Results These perfluorocarbon lipid nanoparticles were uniform and stable,and the mean diameter of them was 171.9 nm. Hepatocellular carcinoma cells were surrounded by the biotinylated particles labelled with NBD. Conclusions A steady perfluorocarbon lipid particles were prepared and the biotinylated particles can be targeted to hepatocellular carcinoma cells with avidin-biotin interaction.
出处 《中华超声影像学杂志》 CSCD 2008年第5期438-441,共4页 Chinese Journal of Ultrasonography
基金 863科技攻关项目(2006AA0224F0) 国家自然科学基金重点项目(30430230) 重庆市自然科学基金面上项目(2005BA5024)
关键词 超声检查 造影剂 肝细胞 Ultrasonography Contrast media Carcinoma,hepatocellular
  • 相关文献

参考文献12

  • 1Unger E, Metzger P, Krupinski E, et al. The use of a thrombus- specific ultrasound contrast agent to detect thrombus in arteriovenous fistulae. Invest Radiol, 2000,35 : 86-89.
  • 2Lindner JR,Song J, Xu F, et al. Noninvasive ultrasound imaging of inflammation using mierobubbles targeted to activated leukoeytes. Circulation, 2000,102 : 2745-2750.
  • 3Wunder A,Straub RH,Gay S,et al. Molecular imaging:novel tools in visualizing rheumatoid arthritis. Rheumatology (Oxford),2005, 44 : 1341-1349.
  • 4Tanaka S, Ioka T, Oshikawa O, et al. Dynamic sonography of hepatic tumors. Am J Roentgenol,2001,177:799-805.
  • 5Lanza GM, Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation,1996,94 : 3334-3340.
  • 6Mattrey RF, Aguirre DA. Advances in contrast media research. Acad Radiol, 2003,10 : 1450-1460.
  • 7陈志南,边惠洁,蒋建利.肝癌单抗研究应用现状与展望[J].华人消化杂志,1998,6(6):461-462. 被引量:10
  • 8Diamandis EP, Christopoulos TK. The biotin-(strept) avidin system: principles and applications in biotechnology. Clin Chem, 1991,37:625-636.
  • 9Mattrey RF, Nemcek AA J r,Shelton R, et al. In vivo estimation of perfluorooctylbromide concentration in tissues. Invest Radiol, 1990, 25:915-921.
  • 10Cyrus T, Winter PM, Caruthers SD, et al. Magnetic resonance nanopartieles for cardiovascular molecular imaging and therapy. Expert Rev Cardiovase Ther,2005,3:705-715.

二级参考文献5

共引文献9

同被引文献45

  • 1彭雪梅,刘慧慧,李雅兰,王仲红,王华东.两种PFC给药方式治疗ALI时血流动力学及病理积分的变化[J].暨南大学学报(自然科学与医学版),2009,30(4):429-433. 被引量:3
  • 2Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol. 1968,3(5) :356 - 366.
  • 3Mattery RF, Scheible FW, Gosink BB, et al. Perfluoroctylbromide: a liver/spleen- specific and tumorimaging ultrasound contrast material. Radiology, 1982, 145(3) : 759 - 762.
  • 4Christiansen JP, Leong PH, Klibanov AL, et al. Noninvasive imaging of myocardial reperfusion injury using leukocyte - targeted contrast echocardiography. Circlation,2002,105(15) : 1764 - 1767.
  • 5Lindner JR, Song J, Christiansen J, et al. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P selection. Circulation, 2001,104(17) : 2107 - 2112.
  • 6Sehgal A, Guaran R. Liquid ventilation. Indian J Chest Dis Allied Sci. 2005,47(3) : 187 - 192.
  • 7Wakabayashi T, Tamura M, Nakaranra T. Partial liquid ventilation with low- dose perfluorochemical and high - frequency oscillation improves oxygenation and lung compliance in a rabbit model of surfactant depletion. Biol Neonate,2006,89(3) : 177 - 182.
  • 8Sloviter H, Kamimoto T. Erythrocyte substitute for perfusion of brain. Nature, 1967, 216(5114) :458 - 460.
  • 9Geyer RP, Monroe RG., Taylor K. Survival of rats having red cells totally replaced with emulsified fluorocarbon. Federation Proc, 1968, 27(1) :384 - 390.
  • 10Lanza GM, Wallace KD, Scott MJ, et al. A novel site- targeted ultrasonic contrast agent with broad biomedical application. Circulation, 1996,94 (12) :3334- 3340.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部